Watch Demo

Global Genotyping Industry

Global Genotyping Industry

  • Publish Date:January 2023

  • Number of Pages:193

  • Report ID:5798664

  • Format:PDF

  • Publisher:Global Industry Analysts

$ 4950

Summary

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Genotyping Market to Reach $38.7 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Genotyping estimated at US$12.3 Billion in the year 2022, is projected to reach a revised size of US$38.7 Billion by 2030, growing at a CAGR of 15.4% over the analysis period 2022-2030. Polymerase Chain Reaction (PCR), one of the segments analyzed in the report, is projected to record a 16% CAGR and reach US$9.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Sequencing segment is readjusted to a revised 16.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3.6 Billion, While China is Forecast to Grow at 14.3% CAGR

The Genotyping market in the U.S. is estimated at US$3.6 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.5 Billion by the year 2030 trailing a CAGR of 14.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.1% and 13.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 11% CAGR.

Select Competitors (Total 39 Featured)
- Affymetrix, Inc.
- Agilent Technologies, Inc.
- Beckman Coulter, Inc.
- Fluidigm Corporation
- GE Healthcare
- Illumina, Inc.
- Life Technologies Corporation
- Qiagen NV
- Roche Diagnostics
- Sequenom, Inc.

Table of contents

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Genotyping - A Prelude
Increasing Incidence of Genetic Diseases Propels the Genotyping
Assays Market
Which Genotyping Techniques Can be Adopted???
Genotyping - Global Key Competitors Percentage Market Share in
2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
SEQUENCING TECHNOLOGIES TAKE THE MAJOR MARKET SHARE
Expanding Applications of DNA Sequencing Offer Significant
Opportunities for the Genotyping Market
Decline in DNA Sequencing Costs Boosts Market Expansion
The Race for $100 Genome Gets Closer
Rising Demand for Hybrid Capture-Based Next Generation Sequencing
Use of Genotyping in Drug Development Drives Market Opportunities
Growth in Adoption of Plant and Animal Sequencing in
Agricultural Research
A Peek into the Genome Sequencing Projects
GENOTYPING REAGENTS DOMINATE THE MARKET BY PRODUCT TYPE

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Genotyping Market Analysis of Annual Sales in
US$ Million for Years 2014 through 2030

Table 2: World Recent Past, Current & Future Analysis for
Genotyping by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 3: World 8-Year Perspective for Genotyping by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets
for Years 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for
Polymerase Chain Reaction (PCR) by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 5: World 8-Year Perspective for Polymerase Chain Reaction
(PCR) by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2023 & 2030

Table 6: World Recent Past, Current & Future Analysis for
Sequencing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 7: World 8-Year Perspective for Sequencing by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2023 & 2030

Table 8: World Recent Past, Current & Future Analysis for
Microarray by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 9: World 8-Year Perspective for Microarray by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Capillary Electrophoresis by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 11: World 8-Year Perspective for Capillary
Electrophoresis by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2023 & 2030

Table 12: World Recent Past, Current & Future Analysis for Mass
Spectrometry by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 13: World 8-Year Perspective for Mass Spectrometry by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030

Table 14: World Recent Past, Current & Future Analysis for
Other Technologies by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 15: World 8-Year Perspective for Other Technologies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for
Reagents & Kits by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 17: World 8-Year Perspective for Reagents & Kits by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030

Table 18: World Recent Past, Current & Future Analysis for
Software & Services by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 19: World 8-Year Perspective for Software & Services by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030

Table 20: World Recent Past, Current & Future Analysis for
Instruments by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 21: World 8-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030

Table 22: World Recent Past, Current & Future Analysis for
Diagnostics & Personalized Medicine by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 23: World 8-Year Perspective for Diagnostics &
Personalized Medicine by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2023 & 2030

Table 24: World Recent Past, Current & Future Analysis for
Pharmacogenomics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 25: World 8-Year Perspective for Pharmacogenomics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030

Table 26: World Recent Past, Current & Future Analysis for
Agricultural Biotechnology by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 27: World 8-Year Perspective for Agricultural
Biotechnology by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2023 & 2030

Table 28: World Recent Past, Current & Future Analysis for
Animal Genetics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 29: World 8-Year Perspective for Animal Genetics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030

Table 30: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 31: World 8-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030

III. MARKET ANALYSIS

UNITED STATES
Genotyping Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in the United States for 2023 (E)
Table 32: USA Recent Past, Current & Future Analysis for
Genotyping by Technology - Polymerase Chain Reaction (PCR),
Sequencing, Microarray, Capillary Electrophoresis, Mass
Spectrometry and Other Technologies - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 33: USA 8-Year Perspective for Genotyping by Technology -
Percentage Breakdown of Value Sales for Polymerase Chain
Reaction (PCR), Sequencing, Microarray, Capillary
Electrophoresis, Mass Spectrometry and Other Technologies for
the Years 2023 & 2030

Table 34: USA Recent Past, Current & Future Analysis for
Genotyping by Product - Reagents & Kits, Software & Services
and Instruments - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 35: USA 8-Year Perspective for Genotyping by Product -
Percentage Breakdown of Value Sales for Reagents & Kits,
Software & Services and Instruments for the Years 2023 & 2030

Table 36: USA Recent Past, Current & Future Analysis for
Genotyping by Application - Diagnostics & Personalized
Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal
Genetics and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 37: USA 8-Year Perspective for Genotyping by Application -
Percentage Breakdown of Value Sales for Diagnostics &
Personalized Medicine, Pharmacogenomics, Agricultural
Biotechnology, Animal Genetics and Other Applications for the
Years 2023 & 2030

CANADA
Table 38: Canada Recent Past, Current & Future Analysis for
Genotyping by Technology - Polymerase Chain Reaction (PCR),
Sequencing, Microarray, Capillary Electrophoresis, Mass
Spectrometry and Other Technologies - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 39: Canada 8-Year Perspective for Genotyping by
Technology - Percentage Breakdown of Value Sales for Polymerase
Chain Reaction (PCR), Sequencing, Microarray, Capillary
Electrophoresis, Mass Spectrometry and Other Technologies for
the Years 2023 & 2030

Table 40: Canada Recent Past, Current & Future Analysis for
Genotyping by Product - Reagents & Kits, Software & Services
and Instruments - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 41: Canada 8-Year Perspective for Genotyping by Product -
Percentage Breakdown of Value Sales for Reagents & Kits,
Software & Services and Instruments for the Years 2023 & 2030

Table 42: Canada Recent Past, Current & Future Analysis for
Genotyping by Application - Diagnostics & Personalized
Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal
Genetics and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 43: Canada 8-Year Perspective for Genotyping by
Application - Percentage Breakdown of Value Sales for
Diagnostics & Personalized Medicine, Pharmacogenomics,
Agricultural Biotechnology, Animal Genetics and Other
Applications for the Years 2023 & 2030

JAPAN
Genotyping Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Japan for 2023 (E)
Table 44: Japan Recent Past, Current & Future Analysis for
Genotyping by Technology - Polymerase Chain Reaction (PCR),
Sequencing, Microarray, Capillary Electrophoresis, Mass
Spectrometry and Other Technologies - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 45: Japan 8-Year Perspective for Genotyping by Technology -
Percentage Breakdown of Value Sales for Polymerase Chain
Reaction (PCR), Sequencing, Microarray, Capillary
Electrophoresis, Mass Spectrometry and Other Technologies for
the Years 2023 & 2030

Table 46: Japan Recent Past, Current & Future Analysis for
Genotyping by Product - Reagents & Kits, Software & Services
and Instruments - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 47: Japan 8-Year Perspective for Genotyping by Product -
Percentage Breakdown of Value Sales for Reagents & Kits,
Software & Services and Instruments for the Years 2023 & 2030

Table 48: Japan Recent Past, Current & Future Analysis for
Genotyping by Application - Diagnostics & Personalized
Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal
Genetics and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 49: Japan 8-Year Perspective for Genotyping by
Application - Percentage Breakdown of Value Sales for
Diagnostics & Personalized Medicine, Pharmacogenomics,
Agricultural Biotechnology, Animal Genetics and Other
Applications for the Years 2023 & 2030

CHINA
Genotyping Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in China for 2023 (E)
Table 50: China Recent Past, Current & Future Analysis for
Genotyping by Technology - Polymerase Chain Reaction (PCR),
Sequencing, Microarray, Capillary Electrophoresis, Mass
Spectrometry and Other Technologies - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 51: China 8-Year Perspective for Genotyping by Technology -
Percentage Breakdown of Value Sales for Polymerase Chain
Reaction (PCR), Sequencing, Microarray, Capillary
Electrophoresis, Mass Spectrometry and Other Technologies for
the Years 2023 & 2030

Table 52: China Recent Past, Current & Future Analysis for
Genotyping by Product - Reagents & Kits, Software & Services
and Instruments - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 53: China 8-Year Perspective for Genotyping by Product -
Percentage Breakdown of Value Sales for Reagents & Kits,
Software & Services and Instruments for the Years 2023 & 2030

Table 54: China Recent Past, Current & Future Analysis for
Genotyping by Application - Diagnostics & Personalized
Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal
Genetics and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 55: China 8-Year Perspective for Genotyping by
Application - Percentage Breakdown of Value Sales for
Diagnostics & Personalized Medicine, Pharmacogenomics,
Agricultural Biotechnology, Animal Genetics and Other
Applications for the Years 2023 & 2030

EUROPE
Genotyping Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Europe for 2023 (E)
Table 56: Europe Recent Past, Current & Future Analysis for
Genotyping by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2022 through 2030 and % CAGR

Table 57: Europe 8-Year Perspective for Genotyping by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2023 & 2030

Table 58: Europe Recent Past, Current & Future Analysis for
Genotyping by Technology - Polymerase Chain Reaction (PCR),
Sequencing, Microarray, Capillary Electrophoresis, Mass
Spectrometry and Other Technologies - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 59: Europe 8-Year Perspective for Genotyping by
Technology - Percentage Breakdown of Value Sales for Polymerase
Chain Reaction (PCR), Sequencing, Microarray, Capillary
Electrophoresis, Mass Spectrometry and Other Technologies for
the Years 2023 & 2030

Table 60: Europe Recent Past, Current & Future Analysis for
Genotyping by Product - Reagents & Kits, Software & Services
and Instruments - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 61: Europe 8-Year Perspective for Genotyping by Product -
Percentage Breakdown of Value Sales for Reagents & Kits,
Software & Services and Instruments for the Years 2023 & 2030

Table 62: Europe Recent Past, Current & Future Analysis for
Genotyping by Application - Diagnostics & Personalized
Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal
Genetics and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 63: Europe 8-Year Perspective for Genotyping by
Application - Percentage Breakdown of Value Sales for
Diagnostics & Personalized Medicine, Pharmacogenomics,
Agricultural Biotechnology, Animal Genetics and Other
Applications for the Years 2023 & 2030

FRANCE
Genotyping Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in France for 2023 (E)
Table 64: France Recent Past, Current & Future Analysis for
Genotyping by Technology - Polymerase Chain Reaction (PCR),
Sequencing, Microarray, Capillary Electrophoresis, Mass
Spectrometry and Other Technologies - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 65: France 8-Year Perspective for Genotyping by
Technology - Percentage Breakdown of Value Sales for Polymerase
Chain Reaction (PCR), Sequencing, Microarray, Capillary
Electrophoresis, Mass Spectrometry and Other Technologies for
the Years 2023 & 2030

Table 66: France Recent Past, Current & Future Analysis for
Genotyping by Product - Reagents & Kits, Software & Services
and Instruments - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 67: France 8-Year Perspective for Genotyping by Product -
Percentage Breakdown of Value Sales for Reagents & Kits,
Software & Services and Instruments for the Years 2023 & 2030

Table 68: France Recent Past, Current & Future Analysis for
Genotyping by Application - Diagnostics & Personalized
Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal
Genetics and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 69: France 8-Year Perspective for Genotyping by
Application - Percentage Breakdown of Value Sales for
Diagnostics & Personalized Medicine, Pharmacogenomics,
Agricultural Biotechnology, Animal Genetics and Other
Applications for the Years 2023 & 2030

GERMANY
Genotyping Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Germany for 2023 (E)
Table 70: Germany Recent Past, Current & Future Analysis for
Genotyping by Technology - Polymerase Chain Reaction (PCR),
Sequencing, Microarray, Capillary Electrophoresis, Mass
Spectrometry and Other Technologies - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 71: Germany 8-Year Perspective for Genotyping by
Technology - Percentage Breakdown of Value Sales for Polymerase
Chain Reaction (PCR), Sequencing, Microarray, Capillary
Electrophoresis, Mass Spectrometry and Other Technologies for
the Years 2023 & 2030

Table 72: Germany Recent Past, Current & Future Analysis for
Genotyping by Product - Reagents & Kits, Software & Services
and Instruments - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 73: Germany 8-Year Perspective for Genotyping by Product -
Percentage Breakdown of Value Sales for Reagents & Kits,
Software & Services and Instruments for the Years 2023 & 2030

Table 74: Germany Recent Past, Current & Future Analysis for
Genotyping by Application - Diagnostics & Personalized
Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal
Genetics and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 75: Germany 8-Year Perspective for Genotyping by
Application - Percentage Breakdown of Value Sales for
Diagnostics & Personalized Medicine, Pharmacogenomics,
Agricultural Biotechnology, Animal Genetics and Other
Applications for the Years 2023 & 2030

ITALY
Table 76: Italy Recent Past, Current & Future Analysis for
Genotyping by Technology - Polymerase Chain Reaction (PCR),
Sequencing, Microarray, Capillary Electrophoresis, Mass
Spectrometry and Other Technologies - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 77: Italy 8-Year Perspective for Genotyping by Technology -
Percentage Breakdown of Value Sales for Polymerase Chain
Reaction (PCR), Sequencing, Microarray, Capillary
Electrophoresis, Mass Spectrometry and Other Technologies for
the Years 2023 & 2030

Table 78: Italy Recent Past, Current & Future Analysis for
Genotyping by Product - Reagents & Kits, Software & Services
and Instruments - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 79: Italy 8-Year Perspective for Genotyping by Product -
Percentage Breakdown of Value Sales for Reagents & Kits,
Software & Services and Instruments for the Years 2023 & 2030

Table 80: Italy Recent Past, Current & Future Analysis for
Genotyping by Application - Diagnostics & Personalized
Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal
Genetics and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 81: Italy 8-Year Perspective for Genotyping by
Application - Percentage Breakdown of Value Sales for
Diagnostics & Personalized Medicine, Pharmacogenomics,
Agricultural Biotechnology, Animal Genetics and Other
Applications for the Years 2023 & 2030

UNITED KINGDOM
Genotyping Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in the United Kingdom for 2023 (E)
Table 82: UK Recent Past, Current & Future Analysis for
Genotyping by Technology - Polymerase Chain Reaction (PCR),
Sequencing, Microarray, Capillary Electrophoresis, Mass
Spectrometry and Other Technologies - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 83: UK 8-Year Perspective for Genotyping by Technology -
Percentage Breakdown of Value Sales for Polymerase Chain
Reaction (PCR), Sequencing, Microarray, Capillary
Electrophoresis, Mass Spectrometry and Other Technologies for
the Years 2023 & 2030

Table 84: UK Recent Past, Current & Future Analysis for
Genotyping by Product - Reagents & Kits, Software & Services
and Instruments - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 85: UK 8-Year Perspective for Genotyping by Product -
Percentage Breakdown of Value Sales for Reagents & Kits,
Software & Services and Instruments for the Years 2023 & 2030

Table 86: UK Recent Past, Current & Future Analysis for
Genotyping by Application - Diagnostics & Personalized
Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal
Genetics and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 87: UK 8-Year Perspective for Genotyping by Application -
Percentage Breakdown of Value Sales for Diagnostics &
Personalized Medicine, Pharmacogenomics, Agricultural
Biotechnology, Animal Genetics and Other Applications for the
Years 2023 & 2030

REST OF EUROPE
Table 88: Rest of Europe Recent Past, Current & Future Analysis
for Genotyping by Technology - Polymerase Chain Reaction (PCR),
Sequencing, Microarray, Capillary Electrophoresis, Mass
Spectrometry and Other Technologies - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 89: Rest of Europe 8-Year Perspective for Genotyping by
Technology - Percentage Breakdown of Value Sales for Polymerase
Chain Reaction (PCR), Sequencing, Microarray, Capillary
Electrophoresis, Mass Spectrometry and Other Technologies for
the Years 2023 & 2030

Table 90: Rest of Europe Recent Past, Current & Future Analysis
for Genotyping by Product - Reagents & Kits, Software &
Services and Instruments - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 91: Rest of Europe 8-Year Perspective for Genotyping by
Product - Percentage Breakdown of Value Sales for Reagents &
Kits, Software & Services and Instruments for the Years 2023 &
2030

Table 92: Rest of Europe Recent Past, Current & Future Analysis
for Genotyping by Application - Diagnostics & Personalized
Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal
Genetics and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 93: Rest of Europe 8-Year Perspective for Genotyping by
Application - Percentage Breakdown of Value Sales for
Diagnostics & Personalized Medicine, Pharmacogenomics,
Agricultural Biotechnology, Animal Genetics and Other
Applications for the Years 2023 & 2030

ASIA-PACIFIC
Genotyping Market Presence - Strong/Active/Niche/Trivial - Key
Competitors in Asia-Pacific for 2023 (E)
Table 94: Asia-Pacific Recent Past, Current & Future Analysis
for Genotyping by Technology - Polymerase Chain Reaction (PCR),
Sequencing, Microarray, Capillary Electrophoresis, Mass
Spectrometry and Other Technologies - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 95: Asia-Pacific 8-Year Perspective for Genotyping by
Technology - Percentage Breakdown of Value Sales for Polymerase
Chain Reaction (PCR), Sequencing, Microarray, Capillary
Electrophoresis, Mass Spectrometry and Other Technologies for
the Years 2023 & 2030

Table 96: Asia-Pacific Recent Past, Current & Future Analysis
for Genotyping by Product - Reagents & Kits, Software &
Services and Instruments - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 97: Asia-Pacific 8-Year Perspective for Genotyping by
Product - Percentage Breakdown of Value Sales for Reagents &
Kits, Software & Services and Instruments for the Years 2023 &
2030

Table 98: Asia-Pacific Recent Past, Current & Future Analysis
for Genotyping by Application - Diagnostics & Personalized
Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal
Genetics and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 99: Asia-Pacific 8-Year Perspective for Genotyping by
Application - Percentage Breakdown of Value Sales for
Diagnostics & Personalized Medicine, Pharmacogenomics,
Agricultural Biotechnology, Animal Genetics and Other
Applications for the Years 2023 & 2030

REST OF WORLD
Table 100: Rest of World Recent Past, Current & Future Analysis
for Genotyping by Technology - Polymerase Chain Reaction (PCR),
Sequencing, Microarray, Capillary Electrophoresis, Mass
Spectrometry and Other Technologies - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 101: Rest of World 8-Year Perspective for Genotyping by
Technology - Percentage Breakdown of Value Sales for Polymerase
Chain Reaction (PCR), Sequencing, Microarray, Capillary
Electrophoresis, Mass Spectrometry and Other Technologies for
the Years 2023 & 2030

Table 102: Rest of World Recent Past, Current & Future Analysis
for Genotyping by Product - Reagents & Kits, Software &
Services and Instruments - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 103: Rest of World 8-Year Perspective for Genotyping by
Product - Percentage Breakdown of Value Sales for Reagents &
Kits, Software & Services and Instruments for the Years 2023 &
2030

Table 104: Rest of World Recent Past, Current & Future Analysis
for Genotyping by Application - Diagnostics & Personalized
Medicine, Pharmacogenomics, Agricultural Biotechnology, Animal
Genetics and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 105: Rest of World 8-Year Perspective for Genotyping by
Application - Percentage Breakdown of Value Sales for
Diagnostics & Personalized Medicine, Pharmacogenomics,
Agricultural Biotechnology, Animal Genetics and Other
Applications for the Years 2023 & 2030

IV. COMPETITION

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.